Artegraft, Inc., a leading name in the medical device industry, is headquartered in the United States and operates extensively across various regions. Founded in 2000, the company has established itself as a pioneer in the development of innovative grafting solutions, particularly for vascular and surgical applications.
Artegraft's core offerings include biologically derived grafts that are designed to enhance patient outcomes through superior integration and performance. Their unique approach to tissue engineering sets them apart in a competitive market, allowing for improved healing and reduced complications.
With a strong commitment to quality and innovation, Artegraft has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The company continues to advance its product line, contributing to the evolving landscape of surgical solutions.
Part of the Sustainability team at Artegraft, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Reported emissions
No reported emissions data is available for Artegraft, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Artegraft, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Artegraft, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project